Alex Zhavoronkov Joins Scientific Computing World’s Inaugural SCW75 List for AI Drug Discovery

3 articles · Updated · geneonline · Jun 4

Scientific Computing World added Alex Zhavoronkov to its inaugural SCW75 list, citing his work in AI-driven drug discovery and longevity research.
The 75-person list recognizes contributors advancing high-performance computing, AI infrastructure and laboratory informatics across scientific research and development.
Zhavoronkov’s selection reflects his leadership at Insilico Medicine, where generative AI platforms are used to identify drug targets and design novel molecules.
The recognition underscores growing attention on researchers applying digital tools at the intersection of technology and life sciences to speed pharmaceutical innovation.

Sources

With its AI platform attracting a $2.75B deal, is Insilico making traditional pharmaceutical R&D obsolete?

Having validated its AI with a lung disease drug, can Insilico now solve the 'engineering problem' of human aging?